BURNABY, British Columbia, May 28, 2015 /PRNewswire/ -- Lungpacer Medical, Inc., a medical device company developing an intravenous catheter-based phrenic-nerve-pacing system announced today that it will be presenting at the Jefferies 2015 Global Healthcare Conference on Thursday, June 4, 2015 in New York City. Doug Evans, PE will present at 11:30 a.m. Eastern Time.
About Lungpacer Medical, Inc.
Lungpacer Medical is a preclinical stage medical device company pioneering the development of neurostimulation systems designed to preserve the integrity and strength of the diaphragm muscle and reduce complications in critically ill patients who require mechanical ventilation. The proprietary Lungpacer system is designed to activate the diaphragm using a temporary, minimally invasive, transvascular nerve stimulation approach that is expected to save many lives, improve patient outcomes and greatly reduce hospital care costs.
The Lungpacer Diaphragm Pacing System is at this time an investigational device only and is not for sale in any country.
For additional information about Lungpacer, please visit www.Lungpacer.com.
SOURCE Lungpacer Medical